Seres Therapeutics, Inc. (MCRB)

15.05 -0.35 (-2.27%) USD  |  NASDAQ  |  Jan 23, 16:00
14.95 -0.10 (-0.66%) After-Hours: 20:00
More

Seres Therapeutics Preferred Stock (10 Year Growth)

Preferred Stock (10 Year Growth) Chart

View Preferred Stock (10 Year Growth) for MCRB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock (10 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock (10 Year Growth) Range, Past 5 Years

View Preferred Stock (10 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock (10 Year Growth) Benchmarks

View Preferred Stock (10 Year Growth) Benchmarks
Start Trial
Altimmune, Inc. --
NovaBay Pharmaceuticals, Inc. --
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. --
Oragenics, Inc. --